Sign inJoin waitlistJoin the waitlist

Katherine Moxley

Physician · Oklahoma Cancer Specialists and Research Institute, LLC

Credentials: · · · · · ·

History

Oklahoma Cancer Specialists and Research Institute, LLC
2023–Present

Gynecologic Oncology
University of Oklahoma College of Medicine
2011–2014
Obstetrics and Gynecology
University of Oklahoma College of Medicine
2007–2011
University of Oklahoma College of Public Health in Oklahoma City
University of Oklahoma College of Medicine
2000–2004

Research

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer
New England Journal of Medicine · 2019 · 385 citations
Multiple biopsies and detection of cervical cancer precursors at colposcopy
Journal of Clinical Oncology · 2015 · 183 citations
Endometrial carcinoma: a review of chemotherapy, drug resistance, and the search for new agents
Review · The Oncologist · 2010 · First of 2 authors · 104 citations

Kathleen Moore
10 papers · 6 as a resident
Joan Walker
9 papers
CM
Cara Mathews
7 papers · 4 as a resident
David Mutch
7 papers
Lisa Landrum
7 papers · 4 as a fellow
Robert Mannel
7 papers
Krishnansu Tewari
6 papers
Michael Gold
6 papers
CA
Carol Aghajanian
5 papers
David Miller
5 papers
David O'Malley
5 papers
Debra Richardson
5 papers

Grants

Mentoring Translational Cancer Research in Oklahoma
National Institute of General Medical Sciences · P20
Project lead · $650.6K · University of Oklahoma Hlth Sciences Ctr

Clinical trials

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2025–2030
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2022–2027